Sign in
4

Changes in Ownership

Chemomab Therapeutics Ltd. Filed Acc 0001178913-23-000076

Chief Scientific Officer sold 13,800 shares at $5.03 ($69,370)

From the SEC's structured data for this filing

Trades in this filing

Mor George Adi · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-03 Sale : show line 1 in the form −7,700 $5.03 $38,706 317,075 D
2023-01-03 Sale : show line 2 in the form −6,100 $5.03 $30,663 251,147 I
Open-market sales · 13,800 sh · avg $5.03 · $69,370

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-03-15 Grant or award : show line 3 in the form Option to Purchase American Depositary Shares +131,698 131,698 D
2016-10-28 Grant or award : show line 4 in the form Option to Purchase American Depositary Shares +33,725 33,725 I
Loading xslF345X03/ownership.xml…